foxo4-dri experience Development of a novel senolytic by precise disruption of FOXO4-p53 complex FOXO4-DRI | FOXO4/p53 Interaction Blocker
FOXO4 DRI FOXO4 p53 Interaction Blocker MedChemExpress Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell FOXO4 an overview ScienceDirect Topics The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $5.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



